Tonix Pharmaceuticals二季度每股亏损高于预期,营收低于预期

异动解读
Aug 15

美国生物制药公司 Tonix Pharmaceuticals Holding Co 第二季度调整后每股亏损3.86美元,高于分析师预期的3.21美元亏损。公司营收为200万美元,同比下降9.5%,也低于分析师预期的243万美元。

华尔街给予托尼克斯制药12个月目标价中位数为65.00美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10